Developing Therapies in Oncology & Skin Health

MedC Biopharma Corporation is a clinical-stage biopharmaceutical company focused on developing and commercializing  novel class of  therapeutics.

Lab Experiment


Four (4) years of developing skin oncology and skin health treatments in high value market products. Currently, two drugs developed towards clinical trials: CTCL Sezary Syndrome –  Skin T-cell Lymphoma,  an orphan condition with high mortality and unmet needs, and CTCL MF. The total estimated market for CTCL is $1.6 Billion market by 2025 (Diligent MR, 2017).

cover photo.jpg

Veterinary Medication

Veterinary Pipeline Opportunity in pet health including Oncology and inflammation related indications with lifesaving  unmet needs